Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques.

Publication date: Jul 27, 2024

The continued evolution of SARS-CoV-2 underscores the need to understand qualitative aspects of the humoral immune response elicited by spike immunization. Here, we combine monoclonal antibody (mAb) isolation with deep B cell receptor (BCR) repertoire sequencing of rhesus macaques immunized with prefusion-stabilized spike glycoprotein. Longitudinal tracing of spike-sorted B cell lineages in multiple immune compartments demonstrates increasing somatic hypermutation and broad dissemination of vaccine-elicited B cells in draining and non-draining lymphoid compartments, including the bone marrow, spleen and, most notably, periaortic lymph nodes. Phylogenetic analysis of spike-specific monoclonal antibody lineages identified through deep repertoire sequencing delineates extensive intra-clonal diversification that shaped neutralizing activity. Structural analysis of the spike in complex with a broadly neutralizing mAb provides a molecular basis for the observed differences in neutralization breadth between clonally related antibodies. Our findings highlight that immunization leads to extensive intra-clonal B cell evolution where members of the same lineage can both retain the original epitope specificity and evolve to recognize additional spike variants not previously encountered.

Open Access PDF

Concepts Keywords
Antibody Animals
Bone Antibodies, Monoclonal
Diversification Antibodies, Monoclonal
Lymphoid Antibodies, Neutralizing
Macaques Antibodies, Neutralizing
Antibodies, Viral
Antibodies, Viral
B-Lymphocytes
COVID-19
COVID-19 Vaccines
COVID-19 Vaccines
Epitopes
Epitopes
Humans
Immunization
Macaca mulatta
Phylogeny
Receptors, Antigen, B-Cell
Receptors, Antigen, B-Cell
SARS-CoV-2
Somatic Hypermutation, Immunoglobulin
Spike Glycoprotein, Coronavirus
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2

Semantics

Type Source Name
disease VO immunized
disease IDO humoral immune response
disease VO immunization
disease IDO cell
disease VO Glycoprotein
disease VO vaccine
disease MESH clonal evolution
disease MESH infection
disease VO vaccination
disease MESH chronic infections
disease MESH Influenza
disease IDO host
disease MESH Tumor
drug DRUGBANK Coenzyme M
disease VO vaccinated
disease IDO blood
disease MESH SARS CoV 2 infection
disease IDO production
drug DRUGBANK Trestolone
drug DRUGBANK Chromium
disease IDO process
disease VO gene
disease VO frequency
disease VO vaccine strain

Original Article

(Visited 4 times, 1 visits today)